Dopamine precursor depletion influences pain affect rather than pain sensation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Tiemann, Laura ^a   Heitmann, Henrik ^a   Schulz, Enrico ^a   Baumkoẗter, Jochen ^a   Ploner, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CATECHOLAMINE DEPLETION; COMPLEX FORMATION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; ELECTROENCEPHALOGRAPHY; FREQUENCY MODULATION; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; MOTOR PERFORMANCE; NERVE STIMULATION; NOCICEPTION; NORMAL HUMAN; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; DEFICIENCY; METABOLISM; PAIN; PAIN THRESHOLD; PHYSIOLOGY; SYNAPTIC TRANSMISSION; YOUNG ADULT;

DOPAMINE; PHENYLALANINE; TYROSINE;

ADULT; DOPAMINE; ELECTROENCEPHALOGRAPHY; HEALTHY VOLUNTEERS; HUMANS; MALE; PAIN; PAIN PERCEPTION; PAIN THRESHOLD; PHENYLALANINE; SYNAPTIC TRANSMISSION; TYROSINE; YOUNG ADULT;

EID: 84899756073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096167     Document Type: Article

References (53)

1. Melzack R (1968) Sensory, motivational and central control determinants of chronic pain: A new conceptual model; Kenshalo D, editor. p. 432 p.
2. Potvin S, Grignon S, Marchand S (2009) Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 63: 390-402.
3. Wood PB (2008) Role of central dopamine in pain and analgesia. Expert Rev Neurother 8: 781-797.
4. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66: 355-474.
5. Altier N, Stewart J (1999) The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65: 2269-2287. (Pubitemid 29531031)
6. Ha AD, Jankovic J (2012) Pain in Parkinson's disease. Mov Disord 27: 485-491.
7. Wasner G, Deuschl G (2012) Pains in Parkinson disease-many syndromes under one umbrella. Nat Rev Neurol 8: 284-294.
8. Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, et al. (2005) Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20: 1557-1563.
9. Schestatsky P, Kumru H, Valls-Sole J, Valldeoriola F, Marti MJ, et al. (2007) Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69: 2162-2169. (Pubitemid 350294696)
10. Bleuler E (1911) Textbook of Psychiatry. Dover Publications, New York.
11. Blumensohn R, Ringler D, Eli I (2002) Pain perception in patients with schizophrenia. J Nerv Ment Dis 190: 481-483. (Pubitemid 34815812)
12. Singh MK, Giles LL, Nasrallah HA (2006) Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 12: 90-102. (Pubitemid 44284091)
13. Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, et al. (2003) Altered dopamine D2 receptor binding in atypical facial pain. Pain 106: 43-48. (Pubitemid 37329612)
14. Hagelberg N, Forssell H, Rinne JO, Scheinin H, Taiminen T, et al. (2003) Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 101: 149-154. (Pubitemid 36044662)
15. Jaaskelainen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, et al. (2001) Role of the dopaminergic system in chronic pain - a fluorodopa-PET study. Pain 90: 257-260. (Pubitemid 32162947)
16. Wood PB, Patterson JC, 2nd, Sunderland JJ, Tainter KH, Glabus MF, et al. (2007) Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8: 51-58. (Pubitemid 46026964)
17. Kernbaum S, Hauchecorne J (1981) Administration of levodopa for relief of herpes zoster pain. JAMA 246: 132-134.
18. Ertas M, Sagduyu A, Arac N, Uludag B, Ertekin C (1998) Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 75: 257-259. (Pubitemid 28160136)
19. Holman AJ, Myers RR (2005) A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52: 2495-2505. (Pubitemid 41117437)
20. Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153: 744-754.
21. Leyton M (2010) Acute Phenylalanine/Tyrosine Depletion. In: Stolerman IP, editor. Encyclopedia of Psychopharmacology. Springer-Verlag, Berlin Heidelberg.
22. Leyton M, Young SN, Pihl RO, Etezadi S, Lauze C, et al. (2000) Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology 22: 52-63.
23. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47: 211-218.
24. Schulz E, Tiemann L, Schuster T, Gross J, Ploner M (2011) Neurophysiological coding of traits and states in the perception of pain. Cereb Cortex 21: 2408-2414.
25. Hoogenboom N, Schoffelen JM, Oostenveld R, Parkes LM, Fries P (2006) Localizing human visual gamma-band activity in frequency, time and space. Neuroimage 29: 764-773. (Pubitemid 43121201)
26. Tiemann L, Schulz E, Gross J, Ploner M (2010) Gamma oscillations as a neuronal correlate of the attentional effects of pain. Pain 150: 302-308.
27. Tiemann L, Schulz E, Winkelmann A, Ronel J, Henningsen P, et al. (2012) Behavioral and neuronal investigations of hypervigilance in patients with fibromyalgia syndrome. PLoS One 7: e35068.
28. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15: 870-878. (Pubitemid 34852500)
29. Badawy AA (2005) Acute tryptophan or tyrosine depletion test: time for reappraisal? J Psychopharmacol 19: 429-430; author reply 431.
30. Garcia-Larrea L, Frot M, Valeriani M (2003) Brain generators of laser-evoked potentials: from dipoles to functional significance. Neurophysiol Clin 33: 279-292. (Pubitemid 38044021)
31. Lorenz J, Garcia-Larrea L (2003) Contribution of attentional and cognitive factors to laser evoked brain potentials. Neurophysiol Clin 33: 293-301. (Pubitemid 38044022)
32. Becker S, Ceko M, Louis-Foster M, Elfassy NM, Leyton M, et al. (2013) Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers. PLoS One 8: e80766.
33. Hagelberg N, Martikainen IK, Mansikka H, Hinkka S, Nagren K, et al. (2002) Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99: 273-279. (Pubitemid 35247550)
34. Martikainen IK, Hagelberg N, Mansikka H, Hietala J, Nagren K, et al. (2005) Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci Lett 376: 149-153. (Pubitemid 40255300)
35. Pertovaara A, Martikainen IK, Hagelberg N, Mansikka H, Nagren K, et al. (2004) Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci 20: 1587-1592. (Pubitemid 39274041)
36. Scott DJ, Heitzeg MM, Koeppe RA, Stohler CS, Zubieta JK (2006) Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 26: 10789-10795.
37. Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, et al. (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25: 3576-3582. (Pubitemid 47020461)
38. Treister R, Pud D, Eisenberg E (2013) The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans. Neurosci Lett 548: 115-119.
39. Treister R, Pud D, Ebstein RP, Eisenberg E (2013) Dopamine transporter genotype dependent effects of apomorphine on cold pain tolerance in healthy volunteers. PLoS One 8: e63808.
40. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, et al. (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62: 2171-2175. (Pubitemid 38787770)
41. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, et al. (2007) Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 78: 1140-1142.
42. Tinazzi M, Del Vesco C, Defazio G, Fincati E, Smania N, et al. (2008) Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials. Pain 136: 117-124. (Pubitemid 351491374)
43. Nandhagopal R, Troiano AR, Mak E, Schulzer M, Bushnell MC, et al. (2010) Response to heat pain stimulation in idiopathic Parkinson's disease. Pain Med 11: 834-840.
44. Tinazzi M, Recchia S, Simonetto S, Tamburin S, Defazio G, et al. (2010) Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials. Mov Disord 25: 213-220.
45. Schultz W (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30: 259-288.
46. Coffeen U, Lopez-Avila A, Ortega-Legaspi JM, del Angel R, Lopez-Munoz FJ, et al. (2008) Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur J Pain 12: 535-543. (Pubitemid 351635555)
47. Lopez-Avila A, Coffeen U, Ortega-Legaspi JM, del Angel R, Pellicer F (2004) Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 111: 136-143. (Pubitemid 39141015)
48. Koob GF (1996) Hedonic valence, dopamine and motivation. Mol Psychiatry 1: 186-189.
49. Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76: 470-485.
50. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, et al. (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55: 325-336. (Pubitemid 47048908)
51. Becker S, Gandhi W, Schweinhardt P (2012) Cerebral interactions of pain and reward and their relevance for chronic pain. Neurosci Lett 520: 182-187.
52. Leknes S, Tracey I (2008) A common neurobiology for pain and pleasure. Nat Rev Neurosci 9: 314-320. (Pubitemid 351430831)
53. Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67: 53-83.